Insulin & Diabetic-Drug Abuse in Bodybuilding
Exogenous insulin used non-therapeutically, the hypoglycemia coma and death risk
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- FDA Approved for diabetes; the bodybuilding use described here is off-label misuse
Reference only. Not medical advice.
What can go wrong
The principal documented harm is severe hypoglycemia causing loss of consciousness, seizures, permanent neuroglycopenic brain damage, and death, particularly when hypoglycemia occurs during sleep or goes unwitnessed. Repeated insulin use also promotes fat gain and, in misuse contexts, is combined with other PEDs that complicate the clinical picture. Diagnosis is frequently delayed because clinicians may not suspect surreptitious insulin.
This is something to take to a clinician. The Atlas can tell you what is known about insulin & diabetic-drug abuse in bodybuilding in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Some bodybuilders inject exogenous insulin (and misuse other diabetic drugs) for its anabolic and nutrient-partitioning effects. In a non-diabetic, this drives blood glucose dangerously low: the dominant and most common adverse effect is hypoglycemia, which without prompt correction progresses to coma, permanent brain injury, and death. A documented case describes a 30-year-old bodybuilder found comatose from cryptic insulin use who sustained severe, prolonged neuroglycopenic brain damage. Because forensic detection is difficult (exogenous insulin with suppressed C-peptide is the diagnostic clue), reviewers believe insulin misuse is more widespread than the sparse case literature suggests.
There is no antidote timer for a hypoglycemic coma, and no 'off switch' once it's injected.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Insulin drives glucose and amino acids into cells and suppresses proteolysis, the basis of the anabolic rationale. In a person with normal pancreatic function, an exogenous dose stacks on top of endogenous insulin, and the resulting glucose fall can be steep and prolonged, especially with rapid-acting analogues, exercise, or missed carbohydrate. The brain depends on glucose; sustained neuroglycopenia causes coma and irreversible injury.
Why non-diabetics are at higher acute risk
A person with diabetes and their care team titrate insulin against measured glucose and carbohydrate. A non-diabetic bodybuilder injecting for anabolism has an intact counter-regulatory system that can be overwhelmed by a supraphysiologic bolus, and no established dosing logic. The window between an 'anabolic' effect and severe hypoglycemia is narrow and highly situation-dependent (fasting, sleep, alcohol, training), which is why deaths cluster around unsupervised use.
Safety in detail
This intervention involves significant physiological effects and requires evaluation and monitoring by a qualified physician. Self-administration without medical oversight carries documented health risks.
- Severe hypoglycemia: coma, seizure, brain injury, death
- Highest danger unwitnessed or during sleep
- No safe self-titration logic for non-diabetic anabolic use
- Delayed diagnosis (surreptitious use not suspected)
What people get wrong
Often said'Insulin is safe because it's a natural hormone'
ActuallyIn a non-diabetic, an exogenous dose can cause fatal hypoglycemia; being endogenous does not make an injected bolus safe.
Often said'You just eat sugar if you go low'
ActuallyHypoglycemia during sleep or unconsciousness cannot be self-treated; that is when deaths occur.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- What is the true prevalence and mortality of insulin misuse in bodybuilding, given detection difficulty?
- How many unexplained sudden deaths in this population involve undetected hypoglycemia?
Legal status
Insulin is diverted from legitimate diabetic supply or obtained gray-market; ease of access belies the acute lethality of misuse.
Status current as of July 2026. Regulatory positions change, sometimes quickly.
At a glance
- Why misused
- Perceived anabolic / nutrient-partitioning effect
- Dominant harm
- Hypoglycemia -> coma, brain injury, death
- No antidote timing
- Rapid glucose correction is the only rescue; delay causes permanent damage
- Detection clue
- High insulin with low C-peptide indicates exogenous source
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Insulin & Diabetic-Drug Abuse in Bodybuilding. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Severe Hypoglycemia Due to Cryptic Insulin Use in a Bodybuilder (case report)2018/2019
A bodybuilder presented comatose from covert insulin use with severe prolonged neuroglycopenic injury
Reviews of insulin misuse in strength athletesvarious
Note that reported cases are few but the problem is likely far more widespread than the literature captures